Guidelines
Genes-Drugs
Alleles
Publications
Meetings
Resources
Working Groups
Members
Contact

ADRA2C CPIC guidelines

CPIC guideline for beta-blockers and CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a health care professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.

CPIC® is a close partner of PharmGKB.
CPIC® is managed at Stanford University & St. Jude Children’s Research Hospital (U24HG013077)
About Us – Contact CPIC® – Licensing

CPIC® is a registered service mark of the US Department of Health & Human Services (HHS).